We are so excited to welcome you in person in Heidelberg to this year's BioRN Annual Conference: "Novel therapeutics:Biotechnology leading the way into the future" on October 1.
Since 2009, each year the BioRN Annual Conference has been a valuable source of top information, lively discussions and networking opportunities with international experts from different fields of the life sciences.
This year Annual Conference presents some of these biotechnology-driven new therapeutical approaches and partnership models for successful drug development.
Keynotes
“Next generation Immunotherapy” by Holger Kissel, BioNTech SE, Vice President Business Alliances
“Development of Bulevirtide/Hepcludex®, the first approved medication to treat chronic Hepatitis D infections.” by Stephan Urban, Heidelberg University Hospital, Head of the Translational Virology Unit
Speakers Dirk Grimm, University of Heidelberg Christiane Kofink, Boehringer Ingelheim Ivan Đikić, Goethe University Frankfurt Claus Kremoser, WMT Therapeutics Michael Zimmermann, EMBL Thomas Hanke, Evotec
Parallel Workshops, from Members to Members
“Futureproofing your Process Development” by Cytiva [more]
"Innovative technologies and statistical methods for successful drug development” by Cytel [more]
“Emerging Biotechnology Venture Capital” by M_Ventures [more]
Speed-networking & Happy Hour
Poster Session
We are thankful to all speakers for being at the heart of the meeting and accepting the invitation to share their exciting research.
We also would like to thank our sponsors for their dedication and financial support which allowed us to organize an excellent program.
You can also join the conference digitally. Register here.
Agenda
More Information
General Information about the event >>
Registration >>
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
